Market Cap 20.04M
Revenue (ttm) 785.92M
Net Income (ttm) -345.70M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -43.99%
Debt to Equity Ratio -1.36
Volume 10,524,400
Avg Vol 32,550,467
Day's Range N/A - N/A
Shares Out 80.28M
Stochastic %K 2%
Beta 1.30
Analysts Hold
Price Target $0.94

Company Profile

WW International, Inc. provides weight management products and services in the United States, Germany, and internationally. It offers various nutritional, activity, behavioral, and lifestyle tools and approaches for individual weight goals, as well as for people taking GLP-1 medications or living with diabetes. The company also provides various digital subscription products to weight loss and weight management business, which provide interactive and personalized resources that allow users to fol...

Industry: Personal Services
Sector: Consumer Cyclical
Phone: 212 589 2700
Address:
675 Avenue of the Americas, 6th Floor, New York, United States
SelbyMan
SelbyMan Aug. 22 at 2:19 PM
$WW weird price action yesterday and today, no?
0 · Reply
SelbyMan
SelbyMan Aug. 19 at 2:35 PM
$WW why we up?
1 · Reply
moneybags77
moneybags77 Aug. 13 at 4:44 PM
$WW lets goooo
0 · Reply
GalacticFiskerShip
GalacticFiskerShip Aug. 12 at 7:08 PM
$WW holding for 100-200$ I'll wait 3 - 4 years for that. Will be an excellent return.
0 · Reply
Tom2772
Tom2772 Aug. 12 at 2:33 PM
$NVO $WW $LLY $NVDA Next Blockbuster FDA approves Alhemo® as once-daily prophylactic treatment to prevent or reduce the frequency of bleeding episodes for adults and children 12 years of age and older with hemophilia A or B (HA/HB) without inhibitors – Alhemo targets a $9.09B U.S. hemophilia prophylaxis market (projected 2030 value) by addressing adherence challenges with its prefilled pen-injector and competing directly with Hemlibra and Hyrnpavzi. – Analysts forecast $1–2B annual sales by 2030 with 20–30% market penetration, positioning Novo Nordisk to capitalize on the 6.9% CAGR growth in prophylactic treatment adoption. https://www.ainvest.com/news/alhemo-fda-approval-hemophilia-inhibitors-game-changer-novo-nordisk-rare-disease-portfolio-2508/
0 · Reply
JarvisFlow
JarvisFlow Aug. 12 at 1:00 PM
Morgan Stanley has adjusted their stance on WW International ( $WW ), setting the rating to Equal-Weight with a target price of 45 → 41.
0 · Reply
HeyShoe
HeyShoe Aug. 12 at 9:28 AM
$FUBO This time is different. $RUN $RADCQ $M $WW IEP FSLY BB NOK BBBY WISH NIO TLRY NIO
1 · Reply
indievestments
indievestments Aug. 11 at 11:37 PM
Wait, this $WW only has 10 million shares out and 300 million net debt? So 600mln EV? 11% interest on the 450 million total debt outstanding so they need to pay that down ASAP. guiding to 140-150 million EBITDA for 2025.
1 · Reply
topstockalerts
topstockalerts Aug. 11 at 9:44 PM
Predecessor net income was $1.191 billion, or $14.67 a share, although WW said that net income was impacted by the company’s reorganization. Successor net income was $1.3 million, or 13 cents a share. For the prior year’s quarter, or the three months ending June 29, 2024, net income was $23.3 million, or 29 cents a share. WW’s second-quarter combined revenue was $189.2 million, down 6.4% from $202.1 million in the same period last year. The one analyst who provided a revenue estimate to FactSet was expecting $178 million. The company said that the revenue decline reflects ongoing headwinds in its behavioral business, although this was partially offset by 55% growth in revenue from its clinical business, driven by subscriptions to compounded GLP-1 semaglutide for weight loss. $WW
1 · Reply
TI7812
TI7812 Aug. 11 at 8:05 PM
$WW you'd think Compounded GLP-1 drugs ain't going away
0 · Reply
Latest News on WW
WW International, Inc. (WW) Q2 2025 Earnings Call Transcript

Aug 11, 2025, 10:46 AM EDT - 12 days ago

WW International, Inc. (WW) Q2 2025 Earnings Call Transcript


WeightWatchers Announces Second Quarter 2025 Results

Aug 11, 2025, 7:00 AM EDT - 12 days ago

WeightWatchers Announces Second Quarter 2025 Results


Top 2 Consumer Stocks That May Collapse This Quarter

Jul 16, 2025, 8:45 AM EDT - 5 weeks ago

Top 2 Consumer Stocks That May Collapse This Quarter

ATAT


WeightWatchers plans to file for bankruptcy to cut debt

May 6, 2025, 4:59 PM EDT - 3 months ago

WeightWatchers plans to file for bankruptcy to cut debt


WW International, Inc. Schedules Investor Conference Call

May 6, 2025, 4:32 PM EDT - 3 months ago

WW International, Inc. Schedules Investor Conference Call


WW International, Inc. Announces First Quarter 2025 Results

May 6, 2025, 4:02 PM EDT - 3 months ago

WW International, Inc. Announces First Quarter 2025 Results


WeightWatchers preparing to file for bankruptcy: report

Apr 9, 2025, 2:49 PM EDT - 4 months ago

WeightWatchers preparing to file for bankruptcy: report


WeightWatchers prepares for bankruptcy, WSJ reports

Apr 9, 2025, 1:49 PM EDT - 4 months ago

WeightWatchers prepares for bankruptcy, WSJ reports


WeightWatchers Prepares for Bankruptcy

Apr 9, 2025, 1:32 PM EDT - 4 months ago

WeightWatchers Prepares for Bankruptcy


WeightWatchers Investor Launches Fight for Board Seats

Apr 3, 2025, 5:30 AM EDT - 5 months ago

WeightWatchers Investor Launches Fight for Board Seats


WW International, Inc. (WW) Q4 2024 Earnings Call Transcript

Feb 27, 2025, 10:54 PM EST - 6 months ago

WW International, Inc. (WW) Q4 2024 Earnings Call Transcript


WW International, Inc. Announces CFO Transition

Nov 27, 2024, 7:00 AM EST - 9 months ago

WW International, Inc. Announces CFO Transition


WW International, Inc. (WW) Q3 2024 Earnings Call Transcript

Nov 6, 2024, 10:59 AM EST - 10 months ago

WW International, Inc. (WW) Q3 2024 Earnings Call Transcript


WW Stock Rises as WeightWatchers Expands Drug Offerings

Oct 9, 2024, 12:50 PM EDT - 11 months ago

WW Stock Rises as WeightWatchers Expands Drug Offerings


WeightWatchers Stock Soars on Copycat Weight-Loss Drug Offering

Oct 8, 2024, 12:40 PM EDT - 11 months ago

WeightWatchers Stock Soars on Copycat Weight-Loss Drug Offering


WeightWatchers CEO Sima Sistani is leaving the company

Sep 27, 2024, 2:11 PM EDT - 11 months ago

WeightWatchers CEO Sima Sistani is leaving the company


WW Parts Ways With President, CEO Sima Sistani

Sep 27, 2024, 11:50 AM EDT - 11 months ago

WW Parts Ways With President, CEO Sima Sistani


WeightWatchers Announces Executive Leadership Transition

Sep 27, 2024, 8:00 AM EDT - 11 months ago

WeightWatchers Announces Executive Leadership Transition


WW International: There May Never Be A Resurrection

Aug 1, 2024, 3:49 PM EDT - 1 year ago

WW International: There May Never Be A Resurrection


SelbyMan
SelbyMan Aug. 22 at 2:19 PM
$WW weird price action yesterday and today, no?
0 · Reply
SelbyMan
SelbyMan Aug. 19 at 2:35 PM
$WW why we up?
1 · Reply
moneybags77
moneybags77 Aug. 13 at 4:44 PM
$WW lets goooo
0 · Reply
GalacticFiskerShip
GalacticFiskerShip Aug. 12 at 7:08 PM
$WW holding for 100-200$ I'll wait 3 - 4 years for that. Will be an excellent return.
0 · Reply
Tom2772
Tom2772 Aug. 12 at 2:33 PM
$NVO $WW $LLY $NVDA Next Blockbuster FDA approves Alhemo® as once-daily prophylactic treatment to prevent or reduce the frequency of bleeding episodes for adults and children 12 years of age and older with hemophilia A or B (HA/HB) without inhibitors – Alhemo targets a $9.09B U.S. hemophilia prophylaxis market (projected 2030 value) by addressing adherence challenges with its prefilled pen-injector and competing directly with Hemlibra and Hyrnpavzi. – Analysts forecast $1–2B annual sales by 2030 with 20–30% market penetration, positioning Novo Nordisk to capitalize on the 6.9% CAGR growth in prophylactic treatment adoption. https://www.ainvest.com/news/alhemo-fda-approval-hemophilia-inhibitors-game-changer-novo-nordisk-rare-disease-portfolio-2508/
0 · Reply
JarvisFlow
JarvisFlow Aug. 12 at 1:00 PM
Morgan Stanley has adjusted their stance on WW International ( $WW ), setting the rating to Equal-Weight with a target price of 45 → 41.
0 · Reply
HeyShoe
HeyShoe Aug. 12 at 9:28 AM
$FUBO This time is different. $RUN $RADCQ $M $WW IEP FSLY BB NOK BBBY WISH NIO TLRY NIO
1 · Reply
indievestments
indievestments Aug. 11 at 11:37 PM
Wait, this $WW only has 10 million shares out and 300 million net debt? So 600mln EV? 11% interest on the 450 million total debt outstanding so they need to pay that down ASAP. guiding to 140-150 million EBITDA for 2025.
1 · Reply
topstockalerts
topstockalerts Aug. 11 at 9:44 PM
Predecessor net income was $1.191 billion, or $14.67 a share, although WW said that net income was impacted by the company’s reorganization. Successor net income was $1.3 million, or 13 cents a share. For the prior year’s quarter, or the three months ending June 29, 2024, net income was $23.3 million, or 29 cents a share. WW’s second-quarter combined revenue was $189.2 million, down 6.4% from $202.1 million in the same period last year. The one analyst who provided a revenue estimate to FactSet was expecting $178 million. The company said that the revenue decline reflects ongoing headwinds in its behavioral business, although this was partially offset by 55% growth in revenue from its clinical business, driven by subscriptions to compounded GLP-1 semaglutide for weight loss. $WW
1 · Reply
TI7812
TI7812 Aug. 11 at 8:05 PM
$WW you'd think Compounded GLP-1 drugs ain't going away
0 · Reply
Estimize
Estimize Aug. 11 at 6:39 PM
$WW reported YoY EPS growth for Q2, -571.43% in Q1. http://www.estimize.com/intro/ww?chart=historical&metric_name=eps&utm_content=WW&utm_
0 · Reply
GDog32
GDog32 Aug. 11 at 6:18 PM
$WW the women running this company do not have a goddamn idea what they are doing.
0 · Reply
YamahaFreak
YamahaFreak Aug. 11 at 6:16 PM
$WW bankruptcy 2.0, f**k WW
0 · Reply
TI7812
TI7812 Aug. 11 at 6:06 PM
$WW $1.00 spread between Bid and Ask is outrageous.
0 · Reply
Moonman562
Moonman562 Aug. 11 at 3:01 PM
$WW https://www.sec.gov/ix?doc=/Archives/edgar/data/0000105319/000095017025106230/ww-20250630.htm
0 · Reply
hi_tech_low_life
hi_tech_low_life Aug. 11 at 2:20 PM
WW International Q2 FY2025 Earnings Call Transcript $WW https://www.benzinga.com/markets/earnings/25/08/47032365/ww-international-q2-fy2025-earnings-call-transcript?utm_source=articleShare
0 · Reply
DARKP00L
DARKP00L Aug. 11 at 1:49 PM
$WW 09:32 on Aug. 11 2025 WeightWatchers Sees Revenue Boost From Semaglutide Prescriptions Despite Subscriber Drop #tradeideas
0 · Reply
OpenOutcrier
OpenOutcrier Aug. 11 at 12:53 PM
$WW (+9.8% pre) WW International shares lifted by upbeat FY25 outlook https://ooc.bz/l/73445
0 · Reply
DARKP00L
DARKP00L Aug. 11 at 12:44 PM
$WW 08:39 on Aug. 11 2025 WW International Sees FY2025 Sales $685.000M-$700.000M vs $737.722M Est #tradeideas
0 · Reply
MoneyFox562
MoneyFox562 Aug. 8 at 10:46 PM
0 · Reply
Moonman562
Moonman562 Aug. 8 at 3:04 AM
$WW https://finance.yahoo.com/news/weightwatchers-appoints-soulcycle-co-founder-145800575.html
0 · Reply
Estimize
Estimize Aug. 8 at 12:24 AM
Wall St is expecting -0.03 EPS for $WW Q2 [Reporting 08/11 BMO] http://www.estimize.com/intro/ww?chart=historical&metric_name=eps&utm_conte
0 · Reply